HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lily Wu Selected Research

tumor-associated transplantation antigen (TSTA)

10/2011Androgen-independent molecular imaging vectors to detect castration-resistant and metastatic prostate cancer.
1/2006Noninvasive indirect imaging of vascular endothelial growth factor gene expression using bioluminescence imaging in living transgenic mice.
1/2006Bioluminescence imaging of systemic tumor targeting using a prostate-specific lentiviral vector.
5/2005Functionality of androgen receptor-based gene expression imaging in hormone refractory prostate cancer.
9/2004Noninvasive imaging of enhanced prostate-specific gene expression using a two-step transcriptional amplification-based lentivirus vector.
11/2003Optimization of adenoviral vectors to direct highly amplified prostate-specific expression for imaging and gene therapy.
3/2002Molecular engineering of a two-step transcription amplification (TSTA) system for transgene delivery in prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lily Wu Research Topics

Disease

47Neoplasms (Cancer)
11/2020 - 05/2002
21Prostatic Neoplasms (Prostate Cancer)
01/2019 - 03/2002
13Neoplasm Metastasis (Metastasis)
01/2020 - 11/2007
6Renal Cell Carcinoma (Grawitz Tumor)
01/2021 - 01/2017
5Breast Neoplasms (Breast Cancer)
01/2021 - 05/2009
4Kidney Neoplasms (Kidney Cancer)
04/2022 - 01/2017
4Carcinogenesis
01/2021 - 05/2008
3Disease Progression
10/2016 - 11/2005
2Hepatocellular Carcinoma (Hepatoma)
10/2018 - 12/2010
2Melanoma (Melanoma, Malignant)
01/2014 - 03/2005
2Atherosclerosis
09/2010 - 02/2010
2AIDS-Related Complex (ARC)
06/2010 - 02/2007
2Herpes Simplex
10/2005 - 01/2003
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2022
1Confusion (Bewilderment)
12/2017
1Communicable Diseases (Infectious Diseases)
12/2017
1Ascites
11/2015
1Endometrial Neoplasms (Endometrial Cancer)
11/2013
1Hypoxia (Hypoxemia)
12/2010
1Colonic Neoplasms (Colon Cancer)
06/2010

Drug/Important Bio-Agent (IBA)

11AndrogensIBA
01/2019 - 03/2002
7Prostate-Specific Antigen (Semenogelase)IBA
01/2018 - 08/2002
7tumor-associated transplantation antigen (TSTA)IBA
10/2011 - 03/2002
6Macrophage Colony-Stimulating FactorIBA
01/2019 - 02/2010
5Proteins (Proteins, Gene)FDA Link
11/2020 - 01/2006
5Androgen Receptors (Androgen Receptor)IBA
01/2018 - 08/2003
4Firefly LuciferasesIBA
01/2020 - 03/2002
4CytokinesIBA
10/2016 - 05/2013
4Phosphotransferases (Kinase)IBA
11/2015 - 11/2006
4LuciferasesIBA
12/2010 - 09/2005
4Thymidine KinaseIBA
10/2005 - 05/2002
3Biomarkers (Surrogate Marker)IBA
01/2018 - 09/2009
35- (3- methoxy- 4- ((4- methoxybenzyl)oxy)benzyl)pyrimidine- 2,4- diamineIBA
11/2015 - 02/2010
3LigandsIBA
02/2013 - 08/2003
3Hormones (Hormone)IBA
10/2011 - 05/2005
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2008 - 10/2005
2RNA Precursors (Precursor, mRNA)IBA
04/2022 - 01/2017
2Indicators and Reagents (Reagents)IBA
11/2020 - 01/2019
2Messenger RNA (mRNA)IBA
11/2020 - 06/2010
2EndoglinIBA
01/2019 - 01/2017
2pexidartinibIBA
01/2019 - 01/2014
2ChemokinesIBA
06/2018 - 10/2016
2UbiquitinIBA
11/2013 - 02/2007
2Macrophage Colony-Stimulating Factor Receptor (Receptor, Macrophage Colony Stimulating Factor)IBA
09/2010 - 02/2010
2ApolipoproteinsIBA
09/2010 - 02/2010
2Mitogen-Activated Protein KinasesIBA
09/2010 - 11/2006
2Vascular Endothelial Growth Factor CIBA
10/2008 - 11/2007
2ProdrugsIBA
06/2006 - 05/2002
1Etanercept (Enbrel)FDA Link
01/2022
1gamma Catenin (Plakoglobin)IBA
01/2021
1Microfilament Proteins (Actin Binding Proteins)IBA
11/2020
1Heterogeneous Nuclear Ribonucleoprotein A1IBA
06/2020
1Capsules (Microcapsules)IBA
01/2020
1Pharmaceutical PreparationsIBA
09/2019
1Docetaxel (Taxotere)FDA Link
01/2019
1MicroRNAs (MicroRNA)IBA
01/2019
1Interleukin-10 (Interleukin 10)IBA
01/2019
1Cadherins (E-Cadherin)IBA
01/2019
1AntibodiesIBA
01/2018
1Anti-Idiotypic AntibodiesIBA
01/2018
1Antiviral Agents (Antivirals)IBA
12/2017
1DNA (Deoxyribonucleic Acid)IBA
12/2017
1RNA Splicing FactorsIBA
01/2017
1Corn Oil (Oil, Corn)IBA
10/2016
1Fish OilsIBA
10/2016
1Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
10/2016
1Radioisotopes (Radionuclides)IBA
01/2016
1RNA (Ribonucleic Acid)IBA
01/2016
1ArginaseIBA
06/2014
1Estrogens (Estrogen)FDA Link
11/2013
1Cyclin-Dependent Kinases (cdk Proteins)IBA
11/2013
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
11/2013
1S-Phase Kinase-Associated Proteins (Skp1 Protein)IBA
11/2013
1Proteasome InhibitorsIBA
11/2013
1Conditioned Culture MediaIBA
05/2013
1Peptides (Polypeptides)IBA
02/2013
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2013
1Therapeutic UsesIBA
01/2013
1Sirolimus (Rapamycin)FDA Link
01/2013
1GD3 ganglioside (GD(3))IBA
03/2011
1Fetal Proteins (Fetoprotein)IBA
12/2010
1thiazolyl blueIBA
12/2010
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
12/2010
1Adrenergic Agents (Adrenergic Drugs)IBA
09/2010
1Propranolol (Inderal)FDA LinkGeneric
09/2010
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
09/2010
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
09/2010
1Tyrosine (L-Tyrosine)FDA Link
09/2010
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
06/2010
1Polycomb-Group ProteinsIBA
05/2010

Therapy/Procedure

19Therapeutics
01/2020 - 10/2003
4Castration
01/2019 - 08/2003
2Aftercare (After-Treatment)
01/2019 - 12/2010
2Drug Therapy (Chemotherapy)
01/2019 - 01/2017
2Intravenous Injections
01/2016 - 03/2005
1Treatment Delay
01/2021
1Liver Transplantation
10/2018
1Time-to-Treatment
01/2016
1Cell- and Tissue-Based Therapy (Cell Therapy)
01/2014
1Radiotherapy
05/2013